Ultrasound therapy developer Theraclion is pointing to two studies that found favorable results from the use of the company's Echopulse technique in treating benign thyroid nodules.
In a study of 20 benign thyroid nodules published in the March issue of Radiology, a research team led by Dr. Roussanka Kovatcheva, PhD, of the University Hospital of Endocrinology in Sofia, Bulgaria found a statistically significant mean thyroid nodule volume reduction of 48.7% six months after the Echopulse procedure. Other findings included maximum nodule volume shrinkage of 93%, as well as improvements in patient satisfaction score, according to Theraclion.
In a second study on 10 benign thyroid nodules by the same group that was published online in the Journal of Therapeutic Ultrasound, the study team found a significant reduction in thyroid nodule volume by a median of 48.8% three months after the procedure. They also observed nodule volume shrinkage of up to 75%, according to the company.
